Alumis to Participate in Upcoming November Investor Conferences
Provided By GlobeNewswire
Last update: Nov 4, 2025
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced that the Company will participate in the following investor conferences:
Read more at globenewswire.com
